Ftse Mib
39.224,71
1,32%
DAX
22.794,11
1,78%
S&P 500
5.956,06
0,01%
NASDAQ
19.075,26
0,26%
Bitcoin
84.997,64
1,11%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Biomea Fusion Inc (BMEA) Biomea Fusion Inc (BMEA) Notizie

Biomea Fusion Inc

BMEA
2,94
0,10 (3,52%)
27 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
15/1/202522:57EDGAR2Form 8-K - Current report
13/1/202515:00GLOBEBiomea Fusion to Become a Diabetes & Obesity Medicines..
07/1/202515:00GLOBEBiomea Fusion Reports New Preclinical Data on..
06/1/202522:57EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/1/202513:00GLOBEBiomea Fusion to Present at the 43rd Annual J.P. Morgan..
20/12/202421:06EDGAR2Form 8-K - Current report
17/12/202414:10GLOBEBiomea Fusion Announces Positive Topline Results from..
17/12/202400:15GLOBEBiomea Fusion to Host Conference Call to Announce Topline..
12/12/202423:02GLOBEBiomea Fusion Announces Oral and Poster Presentations of..
09/12/202422:01GLOBEBiomea Fusion Announces Preliminary Data from Ongoing..
06/12/202414:00GLOBEBiomea Fusion to Host Conference Call to Present initial..
02/12/202422:05GLOBEBiomea Fusion, Inc. Reports Inducement Grant under Nasdaq..
18/11/202414:00GLOBELate-Breaker Oral Presentation Showing New Analysis from the..
01/11/202421:05GLOBEBiomea Fusion, Inc. Reports Inducement Grant under Nasdaq..
31/10/202411:07EDGAR2Form 8-K - Current report
30/10/202421:00GLOBEBiomea Fusion Presents Preclinical Data Showing Icovamenib..
29/10/202422:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/10/202422:06EDGAR2Form 8-K - Current report
29/10/202421:46GLOBEBiomea Fusion Reports Third Quarter 2024 Financial Results..
21/10/202415:00GLOBEBiomea Fusion Announces Approval of “icovamenib” as..
15/10/202422:05GLOBEBiomea Fusion to Host Conference Call and Webcast on..
07/10/202415:00GLOBEBiomea Fusion to Present at the 1st Annual Asian Conference..
01/10/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202415:00GLOBEBiomea Announces Formation of Global Scientific Advisory..
27/9/202422:02EDGAR2Form 8-K - Current report
26/9/202420:00GLOBEFDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1..
01/8/202422:05GLOBEBiomea Fusion, Inc. Reports Inducement Grant under Nasdaq..
31/7/202422:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/7/202422:13EDGAR2Form 8-K - Current report
31/7/202422:05GLOBEBiomea Fusion Reports Second Quarter 2024 Financial Results..
13/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202423:08EDGAR2Form 8-K - Current report
12/6/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:02EDGAR2Form 8-K - Current report
06/6/202422:05GLOBEBiomea Fusion Announces BMF-219 in Diabetes Placed on..
03/6/202422:05GLOBEBiomea Fusion, Inc. Reports Inducement Grant under Nasdaq..
30/5/202415:12GLOBEBiomea Fusion Announces Completion of Enrollment of First 3..
02/5/202422:05GLOBEBiomea Fusion Reports First Quarter 2024 Financial Results..
01/5/202422:10GLOBEBiomea Fusion, Inc. Reports Inducement Grants under Nasdaq..
01/4/202422:10GLOBEBiomea Fusion, Inc. Reports Inducement Grants under Nasdaq..
01/4/202415:02GLOBEBiomea Fusion Highlights Initial Data from the First Two..
01/4/202415:00GLOBEBiomea Fusion Reports Fourth Quarter and Full Year 2023..
07/3/202422:02EDGAR2Form 8-K - Current report
06/3/202409:04GLOBEBiomea Fusion Presents Patient Cohorts in COVALENT-111..
01/3/202422:16GLOBEBiomea Fusion, Inc. Reports Inducement Grants under Nasdaq..
Apertura: 2,95 Min: 2,78 Max: 2,96
Chiusura: 2,84

La tua Cronologia

NASDAQ
BMEA
Biomea Fusion
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci